Table 3.
Risk factors for first-ever CVE.
| Risk factors | HR | p |
|---|---|---|
| Age (per 1 year increase) | 1.035 (1.019–1.051) | <.001 |
| Gender (male vs. female) | 1.028 (0.695–1.520) | .889 |
| History of diabetes (yes vs. no) | 1.890 (1.214–2.942) | .005 |
| History of cardiovascular disease (yes vs. no) | 2.380 (1.453–3.898) | .001 |
| FAR (≥0.107 vs. <0.107) | 1.867 (1.253–2.782) | .002 |
| Body mass index (per 1 kg/m2 increase) | 1.047 (0.989–1.108) | .117 |
| Haemoglobin (per 1 g/L increase) | 0.997 (0.987–1.008) | .598 |
| Leukocyte (per 1 × 109/L increase) | 1.035 (0.965–1.110) | .338 |
| NLR (per 1 unit increase) | 1.011 (0.987–1.035) | .381 |
| PLR (per 1 unit increase) | 1.001 (0.999–1.002) | .248 |
| hs-CRP (per 1 mg/L increase) | 1.009 (0.997–1.021) | .145 |
| Serum creatinine (per 1 μmol/L increase) | 1.000 (0.999–1.000) | .301 |
| Serum urea nitrogen (per 1 mmol/L increase) | 0.992 (0.976–1.008) | .320 |
| Corrected serum calcium (per 1 mmol/L increase) | 1.231 (0.615–2.466) | .557 |
| Serum phosphorus (per 1 mmol/L increase) | 0.975 (0.733–1.297) | .864 |
| Total cholesterol (per 1 mmol/L increase) | 1.116 (0.933–1.334) | .231 |
| Total triglycerides (per 1 mmol/L increase) | 1.101 (0.857–1.415) | .451 |
| Total Kt/V (per 1 unit increase) | 1.017 (0.797–1.297) | .894 |
| Residual renal function (per 1 mL/min/1.73 m2 increase) | 0.989 (0.948–1.033) | .627 |
CVE: cardiovascular event; FAR: fibrinogen/albumin ratio; NLR: neutrophil and lymphocyte ratio; PLR: platelet and lymphocyte ratio; hs-CRP: high-sensitivity C-reactive protein. Bold values means p < 0.05.